Lymphoid tissues and the immune system in mastocytosis

被引:10
作者
Mekori, YA [1 ]
机构
[1] Meir Hosp, Dept Med B, IL-44281 Kefar Sava, Israel
[2] Meir Hosp, Allergy Clin Immunol Unit, IL-44281 Kefar Sava, Israel
[3] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1016/S0889-8588(05)70297-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Involvement of the spleen and lymph nodes is an important manifestation of systemic mastocytosis. With the bone marrow, the lymph nodes and spleen are the organs most commonly infiltrated in mastocytosis. In all categories of mastocytosis, the one constant is that, over time, mast cell numbers in tissues such as skin, gastrointestinal tract, bone marrow, liver, spleen, and lymph nodes tend to increase. Significant mast cell burdens are most obvious in patients with long-standing, indolent mastocytosis or with aggressive forms of the disease, such as seen in categories II and III. Patients in these situations may exhibit a clinically relevant increase in the size of their lymph nodes, liver, and spleen.(18) In routine management of patients with mastocytosis, the lymph nodes and spleen are rarely biopsied and examined unless significant organ dysfunction has developed or unless there is suspicion of a malignant process for which a biopsy is appropriate. Thus, existing data on the pattern of mast cell infiltrations and their consequences in organs such as liver, spleen, or lymph nodes exhibit a bias for disease categories II and III. Similarly, the available information is insufficient to distinguish tissue-specific disease features typical for the various categories of mastocytosis or to correlate the appearance of the mast cells within Ctissues with the category of disease. What is clear, however, is that an examination of lymph; nodes and spleen from patients with mastocytosis does reveal significant pathologic conditions associated with mast cell infiltration.(18).
引用
收藏
页码:569 / +
页数:10
相关论文
共 33 条
[1]   Mast cells and basophils in innate immunity [J].
Abraham, SN ;
Arock, M .
SEMINARS IN IMMUNOLOGY, 1998, 10 (05) :373-381
[2]   Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell dependent cutaneous inflammation [J].
Baram, D ;
Rashkovsky, M ;
Hershkoviz, R ;
Drucker, I ;
Reshef, T ;
Ben-Shitrit, S ;
Mekori, YA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 110 (03) :485-491
[3]  
CLAMAN HN, 1993, MAST CELL HLTH DIS, P653
[4]   DIFFERENT PATTERNS OF SPLEEN INVOLVEMENT IN SYSTEMIC AND MALIGNANT MASTOCYTOSIS - A HISTOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF 3 CASES [J].
DIEBOLD, J ;
RIVIERE, O ;
GOSSELIN, B ;
JANINMERCIER, A ;
CANELHAS, A ;
LETOURNEAU, A ;
AUDOUIN, J .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1991, 419 (04) :273-280
[5]   CYTOKINE PRODUCTION BY MAST-CELLS AND BASOPHILS [J].
GALLI, SJ ;
GORDON, JR ;
WERSHIL, BK .
CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (06) :865-873
[6]  
GALLI SJ, 1999, FUNDAMENTAL IMMUNOLO, P1137
[7]   INDUCTION OF HUMAN IGE SYNTHESIS IN B-CELLS BY MAST-CELLS AND BASOPHILS [J].
GAUCHAT, JF ;
HENCHOZ, S ;
MAZZEI, G ;
AUBRY, JP ;
BRUNNER, T ;
BLASEY, H ;
LIFE, P ;
TALABOT, D ;
FLORESROMO, L ;
THOMPSON, J ;
KISHI, K ;
BUTTERFIELD, J ;
DAHINDEN, C ;
BONNEFOY, JY .
NATURE, 1993, 365 (6444) :340-343
[8]   PROMOTION OF MOUSE FIBROBLAST COLLAGEN GENE-EXPRESSION BY MAST-CELLS STIMULATED VIA THE FC(EPSILON)RI - ROLE FOR MAST CELL-DERIVED TRANSFORMING GROWTH-FACTOR-BETA AND TUMOR-NECROSIS-FACTOR-ALPHA [J].
GORDON, JR ;
GALLI, SJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2027-2037
[9]   LYMPH-NODE FINDINGS IN GENERALIZED MASTOCYTOSIS [J].
HORNY, HP ;
KAISERLING, E ;
PARWARESCH, MR ;
LENNERT, K .
HISTOPATHOLOGY, 1992, 21 (05) :439-446
[10]  
HORNY HP, 1992, CANCER-AM CANCER SOC, V70, P459, DOI 10.1002/1097-0142(19920715)70:2<459::AID-CNCR2820700214>3.0.CO